Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes

Medicine and Dentistry

• Angiotensin 1 Receptor Antagonist 5%
• Angiotensin II 100%
• Brain Natriuretic Peptide 5%
• Cardiac Muscle Cell 100%
• Cardiac Pathology 5%
• Gel Mobility Shift Assay 11%
• Gene Expression 5%
• Genetic Transcription 5%
• Heart Muscle Injury 5%
• Heavy Meromyosin 5%
• Hypoxia 100%
• Hypoxic Injury 5%
• Luciferase Assay 11%
• Mitogen-Activated Protein Kinase 100%
• Morphology 5%
• Myocardin 100%
• Proline 5%
• Serum Response Factor 29%
• Signal Transduction Pathway 5%
• Small Interfering RNA 5%
• Ventricular Hypertrophy 5%

Biochemistry, Genetics and Molecular Biology

• Angiotensin 100%
• Angiotensin II Receptor Type 1 5%
• Cardiac Muscle Cell 100%
• Electrophoretic Mobility Shift Assay 11%
• Extracellular Signal-Regulated Kinases 100%
• Gene Expression 5%
• Genetic Transcription 5%
• Heavy Meromyosin 5%
• Luciferase 11%
• Morphology 5%
• Myocardin 100%
• Natriuretic Peptide 5%
• Proline 5%
• Serum Response Factor 29%
• Signal Transduction 5%
• Small Interfering RNA 5%
• Transcription 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiotensin 1 Receptor Antagonist 5%
• Angiotensin II 100%
• Brain Natriuretic Peptide 5%
• Electrophoretic Mobility Shift Assay 11%
• Heart Muscle Injury 5%
• Heart Ventricle Hypertrophy 5%
• Hypoxia 100%
• Injury 5%
• Luciferase 11%
• Mitogen Activated Protein Kinase 100%
• Myocardin 100%
• Myosin Heavy Chain 5%
• Proline 5%
• Serum Response Factor 29%
• Small Interfering RNA 5%